Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis

List of reports from Roots Analysis

< prev 1    3  4  
Antibody Drug Conjugates Market (4th Edition), 2017-2030
10/27/2017 | published by: Roots Analysis
... years, the market has witnessed an increasing interest from drug developers and healthcare investors alike. Post the commercialization of ADCETRIS® in 2011 and KADCYLA® in 2013, there was a temporary, but evident, decline in the ...  |  read more...
USD 2,499
Modular Facilities in Pharmaceutical / Biotechnology Industry, 2017-2030
10/6/2017 | published by: Roots Analysis
... pressure on drug manufacturers to optimize drug development costs and speed up the drug development process. Specifically, with the rise of personalized therapies and orphan drugs, manufacturers are now expected to produce significantly low volumes ...  |  read more...
USD 2,499
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030
9/26/2017 | published by: Roots Analysis
... antigen, have become a popular and robust treatment option for various diseases. However, despite the success of antibody therapeutics, there are several limitations associated with the use of mono-specific antibodies. It has been reported that ...  |  read more...
USD 2,499
3D Cell Cultures: Products, Technologies and Key Application Areas (2nd Edition), 2017-2030
9/26/2017 | published by: Roots Analysis
... in vivo microenvironment and provide physiologically relevant insights. Cell culture monolayers or 2D cell cultures are known to harbor differences in morphology, growth rate, function, viability and the overall behavior, as compared to those in ...  |  read more...
USD 2,499
Antibody Humanization and Affinity Maturation: Services and Platforms, 2017 – 2030
8/23/2017 | published by: Roots Analysis
... year 2016, Humira®, a monoclonal antibody, generated revenues worth more than USD 16 billion to become the highest selling drug. With a strong development pipeline and high clinical success rate, the market continues to witness ...  |  read more...
USD 2,499
Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017 - 2030
7/28/2017 | published by: Roots Analysis
... pathogenic microorganisms that colonize the gut, mouth, skin and various other parts of the body. Majority of these microorganisms benefit humans by supplementing them with traits that they do not otherwise possess; these include the ...  |  read more...
USD 2,499
Cell Line Development Services Market, 2017-2027
7/26/2017 | published by: Roots Analysis
... till date, and over 1,500 are under clinical development. Additionally, the loss of patent exclusivity of several biologics in the coming years is likely to be followed by the entry of numerous biosimilars as many ...  |  read more...
USD 2,499
Thin Film Photovoltaics Market, 2017 - 2030
6/28/2017 | published by: Roots Analysis
... such as increasing population, advances in technology, rapid industrialization in emerging markets (such as India and China), rising standard of living, and globalization are driving the global demand. In fact, the global economy is predicted ...  |  read more...
USD 1,899
Oncology Drug Discovery Services Market, 2017-2030
6/21/2017 | published by: Roots Analysis
... / or clinical studies. The process of drug discovery is extremely demanding, both in terms of capital expenses and time. Moreover, there is always a high risk of failure associated with R&D programs and, given ...  |  read more...
USD 2,499
Antibody Discovery: Services and Platforms, 2017-2027
6/14/2017 | published by: Roots Analysis
... particularly antibody based therapeutics. Antibodies, because of several advantages such as high specificity and targeted approach, are increasingly becoming crucial for the treatment of a number of diseases. In fact, since 2015, more than 20 ...  |  read more...
USD 2,499
Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2027
6/9/2017 | published by: Roots Analysis
... birth defects. In fact, more than 7,000 genetic disorders have been identified so far and the number is rising. Genetic testing solutions that enable early detection of genetic abnormalities in fetuses and newborns are important ...  |  read more...
USD 2,499
Biopharmaceutical Contract Manufacturing Market, 2017 - 2027
5/18/2017 | published by: Roots Analysis
... RITUXAN®, Lantus®, Avastin®, Herceptin® and REMICADE®) and a robust pipeline of product / therapy candidates, the market is poised for significant growth in the coming years. It is worth mentioning that much of the anticipated ...  |  read more...
USD 2,499
Non-Invasive Cancer Diagnostics Market (2nd Edition), 2017 - 2030
5/17/2017 | published by: Roots Analysis
... million new cancer cases are estimated to be diagnosed in the US alone; during the same time period, close to 0.6 million patients are estimated to die due to cancer. The high cancer mortality rate ...  |  read more...
USD 2,499
Grid Scale Energy Storage Technologies Market, 2017 - 2030
5/2/2017 | published by: Roots Analysis
... has more than doubled between 1990 and 2015 to reach 20,568 TWh. This demand is projected to grow even further; in fact, by 2035, the growth is expected to be in the range of 69% ...  |  read more...
USD 1,899
Cancer Metabolism Based Therapeutics, 2017-2030
4/21/2017 | published by: Roots Analysis
... The pioneering discovery by Otto Warburg in the middle of the 20th century led to the observation that metabolic activity in tumor tissues leads to a ten-fold increase in production of lactate (from glucose) under ...  |  read more...
USD 2,499
Lyophilization Services for Biopharmaceuticals, 2017-2027
4/18/2017 | published by: Roots Analysis
... by FDA over the last three years; this represents around 30% of the total novel drugs approved during this time period. Currently, more than 50% of the drugs in clinical pipeline comprise of biologics. It ...  |  read more...
USD 2,499
BCMA Targeted Therapies, 2017-2030
3/17/2017 | published by: Roots Analysis
... is universally expressed on the surface of multiple myeloma cells. The research focus shifted towards BCMA targeted therapies in 2004, when the role of BCMA was first indicated in the progression of multiple myeloma. It ...  |  read more...
USD 2,499
Cell Therapy Manufacturing Market, 2017-2027
3/3/2017 | published by: Roots Analysis
... practice has now become an integral part of clinical procedures in the space of bone marrow regeneration and organ transplantation. Cell-based therapies are an emerging segment of the overall biopharmaceutical industry. Post the approval of ...  |  read more...
USD 2,499
Deep Learning in Drug Discovery and Diagnostics, 2017 - 2035
2/22/2017 | published by: Roots Analysis
... to algorithms that enable computers to analyze objects and text in videos and images. Fundamentally, deep learning algorithms are designed to analyze and use large volumes of data to improve the capabilities of machines. Companies, ...  |  read more...
USD 2,499
T-Cell Immunotherapy Market (2nd Edition), 2017-2030
1/31/2017 | published by: Roots Analysis
... growing segments of the pharmaceutical industry. Harnessing immune system components for developing therapeutic solutions has demonstrated significant clinical benefit for various diseases areas, specifically against a number of oncological indications. Immunotherapeutics have gradually gained a ...  |  read more...
USD 2,499
Large Volume Wearable Injectors Market (3rd Edition), 2017-2027
1/31/2017 | published by: Roots Analysis
... therapeutic regimen have become the preferred choice of drug administration. The large scale adoption of prefilled syringes, the first ready-to-use injection device to be marketed, demonstrated the growing interest in the concept of such convenient ...  |  read more...
USD 2,499
Prefilled Syringes Market (4th Edition), 2016 - 2026
12/8/2016 | published by: Roots Analysis
... devices have become preferred devices for parenteral administration of drugs. Specifically, the demand for prefilled syringes has been rising strongly over the past several years. A growing number of healthcare facilities are now adopting this ...  |  read more...
USD 2,349
Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016 - 2026
11/18/2016 | published by: Roots Analysis
... is characterized by pain and swelling in and around the joints. It is a systemic disease and is known to affect several joints at the same time or different joints at different times. Hence, it ...  |  read more...
USD 2,349
Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming
11/17/2016 | published by: Roots Analysis
... are also used for prophylactic purposes in patients who have undergone surgery, or immunocompromised patients (cancer patients undergoing chemotherapy). However, the inappropriate use of antibiotics, both in healthcare and food production, has rapidly accelerated an ...  |  read more...
USD 2,349
Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030
10/24/2016 | published by: Roots Analysis
... regulation of several cellular processes. The UPS consists of two separate consecutive steps, ubiquitination and proteasomal degradation. Due to its involvement in multiple metabolic and regulatory functions, the UPS is considered as a vital part ...  |  read more...
USD 2,349
< prev 1    3  4  
US: 800.298.5699
Int'l: +1.240.747.3093
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!